あゆみ製薬株式会社 (Corporate ID: 1010001165443) is a mid-sized company operating in the 製造業 sector headquartered in 東京都中央区銀座4丁目12番15号. Led by 代表取締役 津村重吾. Officially registered in Japan on 2015. Latest operational metrics report workforce: 299 employees, capital: ¥110M JPY. Fully registered under Japan's National Tax Agency Qualified Invoice System (Invoice No: T1010001165443). Official contact (044-833-0381), corporate governance, and multi-year financial statements are openly accessible on Kigyou-list.
Official change history records regarding corporate name, registered address, and legal entity designations synced with Japan National Tax Agency (国税庁).
Reason: 令和1年10月1日東京都中央区銀座四丁目12番15号株式会社AYM A-Co(2010001199250)に合併し解散
13-digit Corporate Number "1010001165443" was officially assigned by the National Tax Agency Commissioner with corporate name "あゆみ製薬株式会社".
Cross-check reviews, press releases, and compliance background across top Japanese portals.
The official representative phone number for あゆみ製薬株式会社 is 044-833-0381 (FAX: 044-811-1524). Head office is located at 東京都中央区銀座4丁目12番15号. Verified contact channels and executive directories are accessible on Kigyou-list.
あゆみ製薬株式会社's official 13-digit National Tax Agency Corporate Number is 1010001165443. It is officially registered as a Qualified Invoice Issuer under Japan's consumption tax invoice system with registration ID T1010001165443.
あゆみ製薬株式会社 is officially registered and headquartered at Postal Code 1040061, 東京都中央区銀座4丁目12番15号. Complete regional jurisdiction and legal relocation history are verified via Japan's National Tax Agency.
Outreach to あゆみ製薬株式会社 or acquire targeted lookalike company datasets.
あゆみ製薬株式会社に関連する公的異動登記および東京都の各カテゴリ別データベースへの直通インデックスです。 最新の法人登記データや採用活動の動向を各ハブにて毎日自動更新しています。
※ Corporate information on this profile is aggregated, verified, and structured based on official open data provided by the National Tax Agency (国税庁) and METI gBizINFO.
あゆみ製薬株式会社 currently employs 299 personnel. Most recently reported annual revenue stands at undisclosed.
The official representative of あゆみ製薬株式会社 is 代表取締役 津村重吾, with a registered capital of ¥110M JPY. It is privately held.
On Kigyou-list, users can review verified financial metrics, legal registry history, corporate signals (hiring, subsidies, trademarks), and export standardized CSV datasets for B2B intelligence.